Armin Tahmasbi Rad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Armin Tahmasbi Rad has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Mu-Ping Nieh
Polymer Program, University of Connecticut, Storrs, CT 06269, USA
4 shared publications Ali Hariri
Department of Nanoengineering University of California San Diego La Jolla CA 92093 USA
1 shared publicationAmanda Ramsdell
Department of Chemical and Bimolecular Engineering University of Connecticut Storrs CT 06269 USA
1 shared publicationArvind Manojkumar
Department of Health & Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, TX, USA
1 shared publicationBen Zhong Tang
Department of Chemistry the Hong Kong University of Science and Technology Hong Kong P. R. China
1 shared publication- Caroline R Garcia
Department of Health & Biomedical Sciences, University of Texas Rio Grande Valley, Brownsville, TX, USA
1 shared publication
Latest Publications
- Open Access
- 1 June 2022
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (13) , 959-978
Effect of Drug-To-Lipid Ratio on Nanodisc-Based Tenofovir Drug Delivery to The Brain for HIV-1 Infection
Background: Combination antiretroviral therapy has significantly advanced HIV-1 infection treatment. However, HIV-1 remains persistent in the brain; the inaccessibility of the blood–brain barrier a...
- 1 June 2022
- Published by Taylor & Francis in Nanomedicine
- Vol. 17 (13) , 959-978
Open AccessEffect of Drug-To-Lipid Ratio on Nanodisc-Based Tenofovir Drug Delivery to The Brain for HIV-1 Infection
Background: Combination antiretroviral therapy has significantly advanced HIV-1 infection treatment. However, HIV-1 remains persistent in the brain; the inaccessibility of the blood–brain barrier a...
- Open Access
- 20 November 2021
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 2 (1) , 2100080
Codelivery of Paclitaxel and Parthenolide in Discoidal Bicelles for a Synergistic Anticancer Effect: Structure Matters
Nanotechnology has long been used to improve the tumor targeting of chemotherapeutics. The structure of these nanocarriers greatly affects their efficacy and toxicity. Herein, structurally stable nanodiscoidal phospholipid bicelles, which are capable of encapsulating anticancer drugs, paclitaxel (PTX) and parthenolide (PTL), are designed. This nanodiscoidal bicelle structure is shown previously to exhibit longer blood circulation, deeper tumor penetration, and increased tumor cell uptake compared with spherical particles of similar compositions. Structural characterization and loading capacity of the PTX‐ and PTL‐ loaded nanodiscs are conducted along with an investigation into the cytotoxicity of the bicelles based on the drug‐to‐lipid ratios of both drugs loaded separately and in combination. A significant synergistic effect between both loaded drugs is also observed in A549 lung cancer and drug‐resistant MDA‐MB‐231 cell lines. An in vivo study using mice bearing subcutaneous A549 tumors shows a long circulation time of the intravenously injected DiR‐loaded bicelles and significant antitumor efficacy of the PTX‐ and PTL‐loaded bicelles. This efficacious self‐assembled nanoparticle system displays great potential as a nanoplatform to codeliver multiple therapeutics or diagnostics for improving cancer therapy.
- 20 November 2021
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 2 (1) , 2100080
Open AccessCodelivery of Paclitaxel and Parthenolide in Discoidal Bicelles for a Synergistic Anticancer Effect: Structure Matters
Nanotechnology has long been used to improve the tumor targeting of chemotherapeutics. The structure of these nanocarriers greatly affects their efficacy and toxicity. Herein, structurally stable nanodiscoidal phospholipid bicelles, which are capable of encapsulating anticancer drugs, paclitaxel (PTX) and parthenolide (PTL), are designed. This nanodiscoidal bicelle structure is shown previously to exhibit longer blood circulation, deeper tumor penetration, and increased tumor cell uptake compared with spherical particles of similar compositions. Structural characterization and loading capacity of the PTX‐ and PTL‐ loaded nanodiscs are conducted along with an investigation into the cytotoxicity of the bicelles based on the drug‐to‐lipid ratios of both drugs loaded separately and in combination. A significant synergistic effect between both loaded drugs is also observed in A549 lung cancer and drug‐resistant MDA‐MB‐231 cell lines. An in vivo study using mice bearing subcutaneous A549 tumors shows a long circulation time of the intravenously injected DiR‐loaded bicelles and significant antitumor efficacy of the PTX‐ and PTL‐loaded bicelles. This efficacious self‐assembled nanoparticle system displays great potential as a nanoplatform to codeliver multiple therapeutics or diagnostics for improving cancer therapy.
- 13 December 2020
- Published by Wiley in Advanced Functional Materials
- Vol. 31 (10) , 2009750
Aggregation‐Enhanced Photoluminescence and Photoacoustics of Atomically Precise Gold Nanoclusters in Lipid Nanodiscs (NANO2)
The authors designed a structurally stable nano‐in‐nano (NANO2) system highly capable of bioimaging via an aggregation‐enhanced NIR excited emission and photoacoustic response achieved based on atomically precise gold nanoclusters protected by linear thiolated ligands [Au25(SCnH2n+1)18, n = 4–16] encapsulated in discoidal phospholipid bicelles through a one‐pot synthesis. The detailed morphological characterization of NANO2 is conducted using cryogenic transmission electron microscopy, small/wide angle X‐ray scattering with the support of molecular dynamics simulations, providing information on the location of Au nanoclusters in NANO2. The photoluminescence observed for NANO2 is 20–60 times more intense than that of the free Au nanoclusters, with both excitation and emission wavelengths in the near‐infrared range, and the photoacoustic signal is more than tripled. The authors attribute this newly discovered aggregation‐enhanced photoluminescence and photoacoustic signals to the restriction of intramolecular motion of the clusters’ ligands. With the advantages of biocompatibility and high cellular uptake, NANO2 is potentially applicable for both in vitro and in vivo imaging, as the authors demonstrate with NIR excited emission from in vitro A549 human lung and the KB human cervical cancer cells.
- 13 December 2020
- Published by Wiley in Advanced Functional Materials
- Vol. 31 (10) , 2009750
Aggregation‐Enhanced Photoluminescence and Photoacoustics of Atomically Precise Gold Nanoclusters in Lipid Nanodiscs (NANO2)
The authors designed a structurally stable nano‐in‐nano (NANO2) system highly capable of bioimaging via an aggregation‐enhanced NIR excited emission and photoacoustic response achieved based on atomically precise gold nanoclusters protected by linear thiolated ligands [Au25(SCnH2n+1)18, n = 4–16] encapsulated in discoidal phospholipid bicelles through a one‐pot synthesis. The detailed morphological characterization of NANO2 is conducted using cryogenic transmission electron microscopy, small/wide angle X‐ray scattering with the support of molecular dynamics simulations, providing information on the location of Au nanoclusters in NANO2. The photoluminescence observed for NANO2 is 20–60 times more intense than that of the free Au nanoclusters, with both excitation and emission wavelengths in the near‐infrared range, and the photoacoustic signal is more than tripled. The authors attribute this newly discovered aggregation‐enhanced photoluminescence and photoacoustic signals to the restriction of intramolecular motion of the clusters’ ligands. With the advantages of biocompatibility and high cellular uptake, NANO2 is potentially applicable for both in vitro and in vivo imaging, as the authors demonstrate with NIR excited emission from in vitro A549 human lung and the KB human cervical cancer cells.
- 26 October 2020
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (1) , e2001414
Graphene‐Based Biomaterials for Bone Regenerative Engineering: A Comprehensive Review of the Field and Considerations Regarding Biocompatibility and Biodegradation
Graphene and its derivatives have continued to garner worldwide interest due to their unique characteristics. Having expanded into biomedical applications, there have been efforts to employ their exceptional properties for the regeneration of different tissues, particularly bone. This article presents a comprehensive review on the usage of graphene‐based materials for bone regenerative engineering. The graphene family of materials (GFMs) are used either alone or in combination with other biomaterials in the form of fillers in composites, coatings for both scaffolds and implants, or vehicles for the delivery of various signaling and therapeutic agents. The applications of the GFMs in each of these diverse areas are discussed and emphasis is placed on the characteristics of the GFMs that have implications in this regard. In tandem and of importance, this article evaluates the safety and biocompatibility of the GFMs and carefully elucidates how various factors influence the biocompatibility and biodegradability of this new class of nanomaterials. In conclusion, the challenges and opportunities regarding the use of the GFMs in regenerative engineering applications are discussed, and future perspectives for the developments in this field are proposed.
- 26 October 2020
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (1) , e2001414
Graphene‐Based Biomaterials for Bone Regenerative Engineering: A Comprehensive Review of the Field and Considerations Regarding Biocompatibility and Biodegradation
Graphene and its derivatives have continued to garner worldwide interest due to their unique characteristics. Having expanded into biomedical applications, there have been efforts to employ their exceptional properties for the regeneration of different tissues, particularly bone. This article presents a comprehensive review on the usage of graphene‐based materials for bone regenerative engineering. The graphene family of materials (GFMs) are used either alone or in combination with other biomaterials in the form of fillers in composites, coatings for both scaffolds and implants, or vehicles for the delivery of various signaling and therapeutic agents. The applications of the GFMs in each of these diverse areas are discussed and emphasis is placed on the characteristics of the GFMs that have implications in this regard. In tandem and of importance, this article evaluates the safety and biocompatibility of the GFMs and carefully elucidates how various factors influence the biocompatibility and biodegradability of this new class of nanomaterials. In conclusion, the challenges and opportunities regarding the use of the GFMs in regenerative engineering applications are discussed, and future perspectives for the developments in this field are proposed.
- 1 April 2017
- Published by Elsevier in Journal of Magnetism and Magnetic Materials
- Vol. 427, 7-13
Micromagnetic Cancer Cell Immobilization and Release for Real-Time Single Cell Analysis
- 1 April 2017
- Published by Elsevier in Journal of Magnetism and Magnetic Materials
- Vol. 427, 7-13
Micromagnetic Cancer Cell Immobilization and Release for Real-Time Single Cell Analysis